Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Multiple organ > FDA808ci-2
  • Cores:
    72
    CASES:
    72
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    8
    Column number:
    9
    Tissue Array Type:
    FFPE
    Species:
    Human
FDA808ci-2
$255.00
Add To Collect

Description: Multiple organ tumor tissue array with cancer adjacent normal tissue, including pathology grade, TNM and clinical stage, 72 cases/72 cores

Details: Multiple organ tumor tissue microarray with cancer adjacent normal tissue, containing 54 cases of tumor of varieties of organ tissue, plus 18 cases of 6 types of adjacent normal organs, single core per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • NAT(*)
  • Malignant(*)
  • Malignant(0)
  • Malignant(IIB G2)
  • Malignant(IB G1)
  • Malignant(IIIB G3)
  • Normal(*)
  • Malignant(I)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIA)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(III)
  • Malignant(IV)
  • _ph
TISSUE ARRAYS
FDA808ci-2
1
2
3
4
5
6
7
8
9
A
Ute
Ute
Ute
Ute
Ute
Ute
Ske
Ske
Ske
B
Ski
Ski
Ski
Ner
Ner
Ner
Lun
Car
Lun
C
Cer
Cer
Cer
Cer
Ova
Ova
Pan
Pan
Tes
D
Tes
Thy
Thy
Bre
Bre
Bre
Spl
Lun
Lun
E
Lun
Eso
Eso
Sto
Int
Int
Col
Col
Rec
F
Rec
Liv
Liv
Kid
Pro
Pro
Ute
Ute
Ute
G
Ute
Ute
Str
Rec
Ski
Ski
Bac
Ret
Abd
H
Med
Lym
Lym
Pel
Bla
Bla
Bon
Ret
Smo
_ph
FDA808ci-2
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type
A1
1 21 F Uterus Adenomatoid hyperplasia of endometrium * * * Normal
A2
2 21 F Uterus Normal endometrium tissue * * * Normal
A3
3 18 F Uterus Normal endometrium tissue * * * Normal
A4
4 35 F Uterine cervix Cancer adjacent cervical canals tissue (hyperplasia) * * * NAT
A5
5 72 F Uterine cervix Cancer adjacent cervix tissue with saccular ectasia * * * NAT
A6
6 65 F Uterine cervix Cancer adjacent cervix tissue * * * NAT
A7
7 21 F Skeletal muscle Normal skeletal muscle tissue * * * Normal
A8
8 49 F Skeletal muscle Cancer adjacent skeletal muscle tissue * * * NAT
A9
9 47 M Skeletal muscle Normal skeletal muscle tissue * * * Normal
B1
10 50 F Skin Cancer adjacent skin tissue * * * NAT
B2
11 37 M Skin Normal skin tissue * * * Normal
B3
12 18 F Skin Normal skin tissue of head * * * Normal
B4
13 33 M Nerve Normal peripheral nerve tissue * * * Normal
B5
14 35 M Nerve Normal peripheral nerve tissue * * * Normal
B6
15 35 M Nerve Normal peripheral nerve tissue * * * Normal
B7
16 22 M Lung Normal mesothelial tissue * * * Normal
B8
17 27 F Cardiac pericardium Normal mesothelial tissue * * * Normal
B9
18 47 M Lung Normal lung and mesothelium tissue * * * Normal
C1
19 41 F Cerebrum Glioblastoma 3--4 * * Malignant
C2
20 65 F Cerebrum Atypical meningioma * * * Malignant
C3
21 15 F Cerebrum Malignant ependymoma * * * Malignant
C4
22 39 F Cerebrum Oligodendroglioma 2 * * Malignant
C5
23 63 F Ovary Serous adenocarcinoma 3 T2N0M0 II Malignant
C6
24 29 F Ovary Adenocarcinoma 2 T3N0M0 III Malignant
C7
25 12 F Pancreas Islet cell tumor * * * Malignant
C8
26 64 M Pancreas Adenocarcinoma 2 T3N0M0 II Malignant
C9
27 32 M Testis Seminoma * T1N0M0 I Malignant
D1
28 30 M Testis Embryonal carcinoma * T2N0M0 I Malignant
D2
29 33 F Thyroid Medullary carcinoma * T3N0M0 II Malignant
D3
30 46 F Thyroid Papillary carcinoma * T4N0M0 III Malignant
D4
31 43 F Breast Invasive ductal carcinoma 1 T2N1M0 IIA Malignant
D5
32 48 F Breast Intraductal carcinoma * TisN0M0 0 Malignant
D6
33 58 F Breast Invasive ductal carcinoma 1--2 T2N1M0 IIB Malignant
D7
34 21 M Spleen Diffuse B-cell lymphoma * * * Malignant
D8
35 61 M Lung Small cell undifferentiated carcinoma * T2N0M0 I Malignant
D9
36 66 M Lung Squamous cell carcinoma 3 T2N0M0 I Malignant
E1
37 42 M Lung Adenocarcinoma 2--3 T2N0M0 IB Malignant
E2
38 67 M Esophagus Neuroendocrine carcinoma * T2N1M0 IIA Malignant
E3
39 63 M Esophagus Adenocarcinoma 3 T3N0M0 IIA Malignant
E4
40 73 F Stomach Signet-ring cell carcinoma * T2N1M0 II Malignant
E5
41 64 F Intestine Adenocarcinoma 3 T4N0M0 II Malignant
E6
42 71 F Intestine Stromal sarcoma * T2N0M0 IIB G2 Malignant
E7
43 72 F Colon Adenocarcinoma 1 T4N0M0 IIB Malignant
E8
44 54 M Colon Interstitialoma * T2N0M0 IIB G2 Malignant
E9
45 36 M Rectum Adenocarcinoma 2 T2N0M0 I Malignant
F1
46 63 F Rectum Moderate malignant interstitialoma * T2N0M0 IIB G2 Malignant
F2
47 55 F Liver Hepatocellular carcinoma 1--2 T3N0M0 IIIA Malignant
F3
48 17 F Liver Hepatoblastoma * * * Malignant
F4
49 60 M Kidney Clear cell carcinoma 1 T2N0M0 II Malignant
F5
50 80 M Prostate Adenocarcinoma (Gleason grade:4 Gleason score:4+5) 3 T4N1M1c IV Malignant
F6
51 77 M Prostate Adenocarcinoma (Gleason grade:3 Gleason score:3+4) 2--3 T2N0M0 II Malignant
F7
52 33 F Uterus Leiomyoma * T2N0M0 IB G1 Malignant
F8
53 50 F Uterus Adenocarcinoma 1--2 T1bN0M0 IB Malignant
F9
54 50 F Uterus Clear cell carcinoma of endometrium * T2bN0M0 IIB Malignant
G1
55 36 F Uterine cervix Squamous cell carcinoma 3 T1bN0M0 IB Malignant
G2
56 49 F Uterine cervix Squamous cell carcinoma 2 T2N0M0 II Malignant
G3
57 20 F Striated muscle Embryonal rhabdomyosarcom of left leg * T1aN0M0 IA Malignant
G4
58 70 F Rectum Malignant melanoma * T4N0M0 IIIB Malignant
G5
59 61 M Skin Basal cell carcinoma of left face * T2N0M0 II Malignant
G6
60 64 M Skin Squamous cell carcinoma of chest wall 2 T3N0M0 II Malignant
G7
61 59 M Back Neurofibroma * * * Malignant
G8
62 1 F Retroperitoneum Neuroblastoma * T2bN0M0 IIIB Malignant
G9
63 60 M Abdominal cavity Malignant mesothelioma * T2N0M0 IIB G2 Malignant
H1
64 49 M Mediastinum Diffuse B-cell lymphoma of lymph node * * * Malignant
H2
65 50 F Lymph node Diffuse B cell lymphoma of right thigh * * * Malignant
H3
66 27 M Lymph node Hodgkin's lymphoma of left groin * * * Malignant
H4
67 19 F Pelvic cavity Anaplastic large cell lymphoma * * * Malignant
H5
68 76 M Bladder Transitional cell carcinoma 2 T3aN0M0 III Malignant
H6
69 62 M Bladder Low grade malignant leiomyosarcoma * T2bN0M0 IB G1 Malignant
H7
70 7 F Bone Osteosarcoma of right femur * T2N0M0 IIIB Malignant
H8
71 48 F Retroperitoneum Spindle cell rhabdomyosarcoma * T2N0M0 IIB Malignant
H9
72 60 F Smooth muscle Moderate malignant leiomyosarcoma of left buttock * T2bN0M0 IIIB G3 Malignant
_pheochromocytoma_
Find overlapping cases with this tissue array:
  • FDA808ci-2
    File Format: .xlsx
    Release Date: 2025-01-17 15:57:38
    Download
1.686695s